Results 1 to 10 of about 377,839 (219)

Antibody Levels at 3-Years Follow-Up of a Third Dose of Measles-Mumps-Rubella Vaccine in Young Adults [PDF]

Vaccines, 2022
Mumps outbreaks and breakthrough infections of measles and rubella have raised concerns about waning of vaccine-induced immunity after two doses of measles-mumps-rubella (MMR) vaccination.
Alienke Wijmenga-Monsuur, Patricia Kaaijk, Rob van Binnendijk   +2 more
exaly   +4 more sources

Measles-Mumps-Rubella Vaccine and COVID-19 Relationship. [PDF]

mBio, 2020
I have read the article by Fidel and Noverr with great interest (1). As told in the article, could measles-mumps-rubella (MMR) vaccine really be a “low-risk–high-reward” measure in COVID-19? However, I have several concerns about their opinion/hypothesis posed in their article (1).
Özdemir Ö.
europepmc   +4 more sources

Completeness of MMR Vaccination and Durability of Vaccine-Induced Antibody Responses in Children with Inflammatory Bowel Disease [PDF]

Biomedicines
Background: Children with IBD are at increased risk of suboptimal maintenance of vaccine-induced immunity, particularly when the MMR vaccination course is incomplete before diagnosis and initiation of immunosuppressive therapy. We conducted a prospective
Ivan S. Samolygo, Alexey A. Tinkov, Marina A. Manina, Anton S. Antishin, Albina S. Pestova, Ekaterina A. Yablokova, Ekaterina V. Prutskova, Mikhail P. Kostinov, Svetlana I. Erdes   +8 more
doaj   +2 more sources

Difficulties in Eliminating Measles and Controlling Rubella and Mumps: A Cross-Sectional Study of a First Measles and Rubella Vaccination and a Second Measles, Mumps, and Rubella Vaccination

PLoS ONE, 2014
BackgroundThe reported coverage of the measles-rubella (MR) or measles-mumps-rubella (MMR) vaccine is greater than 99.0% in Zhejiang province. However, the incidence of measles, mumps, and rubella remains high.
Zhifang Wang, Rui Yan, Hanqing He, Qian Li, Guohua Chen, Shengxu Yang, Enfu Chen   +6 more
exaly   +3 more sources

Mumps resurgence despite MMR: Limitations of current vaccines and the need for new strategies [PDF]

Human Vaccines & Immunotherapeutics
Mumps has reemerged globally despite widespread use of the measles – mumps – rubella (MMR) vaccine, contrasting with the successful control of measles and rubella.
Vipin M. Vashishtha, Unmesh Upadhyay
doaj   +2 more sources

A cross-sectional study of seroprevalence in Armenia, 2025: measles, mumps, rubella, and diphtheria [PDF]

Frontiers in Public Health
IntroductionPrevention and control of vaccine-preventable infections is a key component of maintaining public health, and the overall state of immunity is the determining factor.Objective of the studyTo study herd immunity of the Armenian population to ...
A. Y. Popova, V. S. Smirnov, S. A. Egorova, S. A. Atoyan, S. A. Atoyan, L. V. Buts, A. M. Milichkina, G. G. Melik-Andreasyan, G. G. Melik-Andreasyan, O. B. Zhimbaeva, S. S. Grigoryan, S. S. Grigoryan, Z. G. Grigoryan, E. M. Danilova, E. S. Ramsay, V. G. Drobyshevskaya, D. A. Starkova, K. A. Frolova, N. N. Zotkin, T. V. Arbuzova, L. V. Suzhaeva, A. V. Svarval, V. A. Ivanov, O. V. Kotsar, V. Y. Smolensky, A. A. Totolian   +25 more
doaj   +2 more sources

Dynamics of the Antibody Response After a Third Dose of Measles-Mumps-Rubella Vaccine Indicate a Slower Decline Compared With a Second Dose [PDF]

Open Forum Infectious Diseases, 2020
Anne-Marie Buisman, Patricia Kaaijk, Rob van Binnendijk   +2 more
exaly   +2 more sources

Determination of ELISA reactive mumps IgG antibodies in MMR vaccine recipients in comparison with MMR vaccine naive children: A cross sectional study [PDF]

Scripta Medica, 2021
Background/Aim: Mumps is by vaccine preventable infectious disease characterised by parotitis. In India mumps vaccines are not currently used under National Immunisation Programme (NIP).
Gupta Riya, Saxena Naveen, Gupta Parul
doaj   +1 more source

Safety and immunological effectiveness of the domestic combined trivaccine for the prevention of measles, rubella and mumps Vaktrivir^® in children 12 months and 6 years of age (results of a simple blind multicenter comparative randomized clinical trial)

Эпидемиология и вакцинопрофилактика, 2021
Relevanc. Measles, mumps and rubella, despite many years of vaccination, retain their epidemiological and social significance at the present time. The aim of the work is to study the safety and immunogenicity. Of the vaccine for the prevention of measles,
I. V. Feldblium, V. V. Romanenko, K. A. Subbotina, M. G. Menshikova, I. A. Okuneva, A. Y. Musikhina, T. E. Snitkovskaya, N. I. Marcovich, A. E. Ershov, D. M. Trofimov   +9 more
doaj   +1 more source

Quality analysis of a combined domestic vaccine for the prevention of measles, rubella and mumps

Вопросы вирусологии, 2022
Introduction. The need to maintain a high level of vaccination coverage against measles, rubella and mumps in conditions of an increased risk of outbreaks of infections due to violations of vaccination tactics associated with the pandemic of coronavirus ...
Anna S. Binyatova, Tatyana N. Unasova, Tatyana N. Iliasova, Karine А. Sarkisyan, Olga V. Fadeikina, Artashes A. Movsesyants   +5 more
doaj   +1 more source